These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Clinical efficacy of aztreonam in refractory infections in children]. Ogura H; Hamada F; Fujieda M; Matsumoto K; Araki K; Ogura Y; Kuramitsu M; Kurashige T; Kitamura I Jpn J Antibiot; 1985 Nov; 38(11):3349-57. PubMed ID: 4094068 [TBL] [Abstract][Full Text] [Related]
43. The clinical use of aztreonam. Schönwald S; Schoss-Vidensek Z; Car V; Krznar B Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450 [TBL] [Abstract][Full Text] [Related]
44. Safety profile of aztreonam in clinical trials. Newman TJ; Dreslinski GR; Tadros SS Rev Infect Dis; 1985; 7 Suppl 4():S648-55. PubMed ID: 2934785 [TBL] [Abstract][Full Text] [Related]
45. Overall clinical experience with aztreonam in the treatment of intraabdominal infections. Henry SA Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331 [TBL] [Abstract][Full Text] [Related]
46. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections. Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296 [TBL] [Abstract][Full Text] [Related]
47. Once daily ceftriaxone for central nervous system infections and other serious pediatric infections. Yogev R; Shulman ST; Chadwick EG; Davis AT; Glogowski W Pediatr Infect Dis; 1986; 5(3):298-303. PubMed ID: 3725639 [TBL] [Abstract][Full Text] [Related]
48. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients. Rolston KV; Bodey GP; Elting L Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294 [TBL] [Abstract][Full Text] [Related]
49. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli. DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368 [TBL] [Abstract][Full Text] [Related]
50. Aztreonam for treating meningitis caused by gram-negative rods. Kilpatrick M; Girgis N; Farid Z; Bishay E Scand J Infect Dis; 1991; 23(1):125-6. PubMed ID: 2028226 [TBL] [Abstract][Full Text] [Related]
51. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia. Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947 [TBL] [Abstract][Full Text] [Related]
52. Aztreonam: early clinical studies in New Jersey. Johnson ES; Eng RK; Perez EM; Smith LG N J Med; 1986 Jan; Spec No():26-9. PubMed ID: 3513061 [No Abstract] [Full Text] [Related]
53. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy. Cook JL Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557 [TBL] [Abstract][Full Text] [Related]
54. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis. Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475 [TBL] [Abstract][Full Text] [Related]
55. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli]. Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352 [TBL] [Abstract][Full Text] [Related]